These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 36455536

  • 1. The Effect of Prostaglandin Analogs on Central Corneal Thickness of Patients with Glaucoma or Ocular Hypertension: A Systematic Review.
    Lu Y, Zhong E, Wu J, Cao Y.
    Ophthalmic Res; 2023; 66(1):431-444. PubMed ID: 36455536
    [Abstract] [Full Text] [Related]

  • 2. Effect of prostaglandin analogues on central corneal thickness in patients with glaucoma: A systematic review and meta-analysis with trial sequential analysis.
    Kadri R, Shetty A, Parameshwar D, Kudva AA, Achar A, Shetty J.
    Indian J Ophthalmol; 2022 May; 70(5):1502-1512. PubMed ID: 35502015
    [Abstract] [Full Text] [Related]

  • 3. Selective laser trabeculoplasty is safe and effective in patients previously treated with prostaglandin analogs: An evidence-based review.
    Ruiz-Lozano RE, Alamillo-Velazquez J, Ortiz-Morales G, Garza-Garza LA, Quiroga-Garza ME, Alvarez-Guzman C, Rodriguez-Garcia A.
    Int Ophthalmol; 2023 Feb; 43(2):677-695. PubMed ID: 35962295
    [Abstract] [Full Text] [Related]

  • 4. Changes in central corneal thickness over time: the ocular hypertension treatment study.
    Brandt JD, Gordon MO, Beiser JA, Lin SC, Alexander MY, Kass MA, Ocular Hypertension Treatment Study Group.
    Ophthalmology; 2008 Sep; 115(9):1550-6, 1556.e1. PubMed ID: 18378313
    [Abstract] [Full Text] [Related]

  • 5. The effect of prostaglandin analogs on the biomechanical properties and central thickness of the cornea of patients with open-angle glaucoma: a 3-year study on 108 eyes.
    Tsikripis P, Papaconstantinou D, Koutsandrea C, Apostolopoulos M, Georgalas I.
    Drug Des Devel Ther; 2013 Sep; 7():1149-56. PubMed ID: 24115838
    [Abstract] [Full Text] [Related]

  • 6. [Impact of prostaglandin-F(2alpha)-analogues and carbonic anhydrase inhibitors on central corneal thickness -- a cross-sectional study on 403 eyes].
    Viestenz A, Martus P, Schlötzer-Schrehardt U, Langenbucher A, Mardin CY.
    Klin Monbl Augenheilkd; 2004 Sep; 221(9):753-6. PubMed ID: 15459842
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationship between travoprost and central corneal thickness in ocular hypertension and open-angle glaucoma.
    Harasymowycz PJ, Papamatheakis DG, Ennis M, Brady M, Gordon KD, Travoprost Central Corneal Thickness Study Group.
    Cornea; 2007 Jan; 26(1):34-41. PubMed ID: 17198011
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Meta-analysis of randomized controlled trials comparing selective laser trabeculoplasty with prostaglandin analogue in the primary treatment of open-angle glaucoma or ocular hypertention].
    Peng W, Zhong X, Yu M.
    Zhonghua Yan Ke Za Zhi; 2014 May; 50(5):343-8. PubMed ID: 25052803
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use in ocular hypertension and open angle glaucoma.
    Hu J, Vu JT, Hong B, Gottlieb C.
    Br J Ophthalmol; 2020 Aug; 104(8):1040-1044. PubMed ID: 32532763
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.